WEN:NASDAQWendy's Company (The) Analysis
Data as of 2026-08-08 - not real-time
$7.69
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At $7.69, The Wendy's Company shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 4.9%. With RSI at 52.3 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $6.97 up to resistance at $8.03.
On valuation the read is fair — an earnings multiple of 11.7, absent a reliable peer benchmark. The 7.27% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 63.3%, a beta of 0.36 and a maximum drawdown of 42.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
On valuation the read is fair — an earnings multiple of 11.7, absent a reliable peer benchmark. The 7.27% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 63.3%, a beta of 0.36 and a maximum drawdown of 42.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
DUBLIN, Ohio, July 9, 2026 /PRNewswire/ -- The Wendy's Company Nasdaq: WEN will release its second quarter 2026 results...Fast-food chain Wendy’s NASDAQ:WEN reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up...New leadership shares initial assessment while formulating comprehensive turnaround plan Generated revenue of $571...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 7.72
- MACD momentum is positive
- 30-day volatility of 63.3%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 7.72
- 30-day volatility of 63.3%
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E ratio of 11.7
- Return on equity of 108.0%
- Elevated debt-to-equity of 3381
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin5.72%
P/E Ratio11.7
ROE108.04%
ROA3.80%
Debt/Equity3380.61
P/B Ratio12.7
Op. Cash Flow$358.5M
Free Cash Flow$171.9M
Technical Analysis
TrendNeutral
RSI52.3
Support$6.97
Resistance$8.03
MA 20$7.53
MA 50$7.40
MA 200$7.72
MACDBullish
VolumeStable
Fear & Greed Index94.82
Valuation
Target Price$7.75
Upside/Downside0.78%
GradeFair
TypeValue
Dividend Yield7.27%
Risk Assessment
Beta0.36
Volatility63.33%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.